Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system

被引:135
作者
Hanawa, H
Hematti, P
Keyvanfar, K
Metzger, ME
Krouse, A
Donahue, RE
Kepes, S
Gray, J
Dunbar, CE
Persons, DA
Nienhuis, AW
机构
[1] St Jude Childrens Res Hosp, Expt Hematol Div, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2004-01-0045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High-titer, HIV-1-based lentiviral vector particles were found to traniduce cytokine-mobilized rhesus macaque CD34(+) cells and clonogenic progenitors very poorly (< 1%), reflecting the postentry restriction in rhesus cells to HIV infection. To overcome this barrier, we developed a simian immunodeficiency virus (SIV)-based vector system. A single exposure to a low concentration of amphotropic pseudotyped SIV vector particles encoding the green fluorescent protein (GFP) resulted in gene transfer into 68% +/- 1 % of rhesus bulk CD34(+) cells and 75% +/- 1% of clonogenic progenitors. Polymerase chain reaction (PCR) analysis of DNA from individual hematopoietic colonies confirmed these relative transduction efficiencies. To evaluate SIV vector-mediated stem cell gene transfer in vivo, 3 rhesus macaques underwent transplantation with transduced, autologous cytokine-mobilized peripheral blood CD34+ cells following myeloalblative conditioning. Hematopoietic reconstitution was rapid, and an average of 18% +/- 8% and 15% +/- 7% GFP-positive granulocytes and monocyles, respectively, were observed 4 to 6 months after transplantation, consistent with the average vector copy number of 0.19 +/- 0.05 in peripheral blood leukocytes as determined by real-time PCR. Vector insertion site analysis demonstrated polyclonal reconstitution with vector-containing cells. SIV vectors appear promising for evaluating gene therapy approaches in nonhuman primate models. (C) 2004 by The American Society of Hematology
引用
收藏
页码:4062 / 4069
页数:8
相关论文
共 80 条
  • [1] Ailles LE, 2002, CURR TOP MICROBIOL, V261, P31
  • [2] Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
    Aiuti, A
    Slavin, S
    Aker, M
    Ficara, F
    Deola, S
    Mortellaro, A
    Morecki, S
    Andolfi, G
    Tabucchi, A
    Carlucci, F
    Marinello, E
    Cattaneo, F
    Vai, S
    Servida, P
    Miniero, R
    Roncarolo, MG
    Bordignon, C
    [J]. SCIENCE, 2002, 296 (5577) : 2410 - 2413
  • [3] Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein
    Amsellem, S
    Pflumio, F
    Bardinet, D
    Izac, B
    Charneau, P
    Romeo, PH
    Dubart-Kupperschmitt, A
    Fichelson, S
    [J]. NATURE MEDICINE, 2003, 9 (11) : 1423 - 1427
  • [4] Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34+ cells
    An, DS
    Wersto, RP
    Agricola, BA
    Metzger, ME
    Lu, S
    Amado, RG
    Chen, ISY
    Donahue, RE
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (03) : 1286 - 1295
  • [5] Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques
    An, DS
    Kung, SKP
    Bonifacino, A
    Wersto, RP
    Metzger, ME
    Agricola, BA
    Mao, SH
    Chen, ISY
    Donahue, RE
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (08) : 3547 - 3555
  • [6] Side effects of retroviral gene transfer into hematopoietic stem cells
    Baum, C
    Düllmann, J
    Li, ZX
    Fehse, B
    Meyer, J
    Williams, DA
    von Kalle, C
    [J]. BLOOD, 2003, 101 (06) : 2099 - 2114
  • [7] Restriction of lentivirus in monkeys
    Besnier, C
    Takeuchi, Y
    Towers, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) : 11920 - 11925
  • [8] Retroviral-mediated gene transfer of gp91(phox) into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease
    Bjorgvinsdottir, H
    Ding, CJ
    Pech, N
    Gifford, MA
    Li, LL
    Dinauer, MC
    [J]. BLOOD, 1997, 89 (01) : 41 - 48
  • [9] Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients
    Bowman, JE
    Reese, JS
    Lingas, KT
    Gerson, SL
    [J]. MOLECULAR THERAPY, 2003, 8 (01) : 42 - 50
  • [10] Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer
    Bunting, KD
    Sangster, MY
    Ihle, JN
    Sorrentino, BP
    [J]. NATURE MEDICINE, 1998, 4 (01) : 58 - 64